Table 1b.
ICCC/ICD-O-3** Codes | Ever Exposed* | Never Exposed | |
---|---|---|---|
Hematopoietic cancers | 011–015, 021–025 | 559 (9.8%) | 5162 (90.2%) |
Leukemias | 011–015 | 492 (9.6%) | 4608 (90.4%) |
ALL | 011 | 399 (9.7%) | 3722 (90.3%) |
AML | 012 | 72 (9.7%) | 668 (90.3%) |
Lymphomas | 021–025 | 67 (10.8%) | 554 (89.2%) |
Non-Hodgkin’s Lymphoma | 022–023 | 16 (9.5%) | 152 (90.5%) |
CNS tumors | 031–037 | 218 (9.2%) | 2162 (90.8%) |
Ependymoma | 031 | 22 (7.7%) | 264 (92.3%) |
Astrocytoma | 032 | 83 (8.3%) | 918 (91.7%) |
Neuroblastoma | 041 | 106 (7.7%) | 1275 (92.3%) |
Retinoblastoma | 050 | 68 (9.2%) | 675 (90.9%) |
Unilateral RB | 050 | 46 (9.0%) | 467 (91.0%) |
Bilateral RB | 050 | 22 (9.9%) | 201 (90.1%) |
Wilms tumor | 061 | 92 (8.7%) | 965 (91.3%) |
Hepatoblastoma | 071 | 28 (8.2%) | 314 (91.8%) |
Soft Tissue sarcomas | 091–095 | 67 (9.5%) | 639 (90.5%) |
Germ Cell tumors | 101–105 | 61 (13.5%) | 388 (86.5%) |
Yolk Sac tumors | 101–105,**9071 | 22 (12.2%) | 159 (87.9%) |
Teratomas | 101–105,**9080 | 34 (16.4%) | 171 (83.6%) |
Controls | 23,956 (8.9%) | 246,717 (91.1%) |
Children and pregnant women living within 3km of dichloromethane releases
ICD-O-3 Code